Poly(POG)n loaded with recombinant human bone morphogenetic protein-2 accelerates new bone formation in a critical-sized bone defect mouse model

Abstract

Background Delivery of bone morphogenetic protein-2 (BMP-2) via animal-derived absorbable collagen materials is used for the treatment of large bone defects. However, the administration of bovine proteins to humans is associated with the risk of zoonotic complications. We therefore examined the effect of combining BMP-2 with collagen-like peptides, poly(POG)n, in a critical-sized bone defect mouse model. Methods A 2-mm critical-sized bone defect was created in the femur of 9-week-old male C57/BL6J mice. Mice were randomly allocated into one of four treatment groups (n = 6 each): control (no treatment), poly(POG)n only, 0.2 μg, or 2.0 μg BMP-2 with poly(POG)n. New bone formation was monitored using soft X-ray radiographs, and bone formation at the bone defect site was examined using micro-computed tomography and histological examination at 4 weeks after surgery. Results Administration of 2.0 μg of BMP-2 with poly(POG)n promoted new bone formation and resulted in greater bone volume and bone mineral content than that observed in the control group and successfully achieved consolidation. In contrast, bone formation in all other groups was scarce. Conclusions Our findings suggest the potential of BMP-2 with poly(POG)n as a material, free from animal-derived collagen, for the treatment of large bone defects.

Relationship between BMP2/9 Levels and Spinal Function and Quality of Life in Patients with Severe Scoliosis after PVCR

“…Bone graft fusion is an important factor affecting the efficacy of PVCR surgery. BMP can induce bone formation and irreversibly promote the differentiation of mesenchymal cells into chondrocytes and bone cells [12]. Among all BMP protein families, BMP2 and BMP9 have the strongest osteogenic ability; they can also induce the formation and deposition of calcium phosphate in bone, which is conducive to repairing bone and joint damage [13,14].…”

A Clinical Study on the Effect of Different Ratios of Recombinant Human Bone Morphogenetic Protein-2 Compound to Autogenous Bone on Cervical Interbody Fusion Based on Smart Healthcare

“…Nowadays, the development of substitute materials such as the artificial bone has enabled ACDF with more material choices. Scholars have found that the recombinant human bone morphogenetic protein-2 (rhBMP-2) can accelerate the generation rate of cells, enhance the defect repairability of bone, and then fully optimize the effect of cervical interbody fusion [ 7 – 10 ]. It is an indisputable fact in academia that rhBMP-2 can improve the fusion rate of ACDF, but the optimal dosage is still not clear.…”